Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 453,498Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 16PF PRISM CV

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

AXITINIB

US Patent Number : 10570202

Drug Substance Claim :

Drug Product Claim :

Application Number : 202324

Patent Use Code : U-2844

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-02-03

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

AXITINIB

US Patent Number : 10570202

Drug Substance Claim :

Drug Product Claim :

Application Number : 202324

Patent Use Code : U-2844

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-02-03

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

AXITINIB

US Patent Number : 10869924

Drug Substance Claim :

Drug Product Claim :

Application Number : 202324

Patent Use Code : U-3044

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-01-12

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

AXITINIB

US Patent Number : 10869924

Drug Substance Claim :

Drug Product Claim :

Application Number : 202324

Patent Use Code : U-3044

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-01-12

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

AXITINIB

US Patent Number : 8791140

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 202324

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-12-14

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

AXITINIB

US Patent Number : 6534524

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202324

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-04-29

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

AXITINIB

US Patent Number : 6534524

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202324

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-04-29

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

AXITINIB

US Patent Number : 8791140

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 202324

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-12-14

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

AXITINIB

US Patent Number : 6534524*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 202324

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-10-29

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

AXITINIB

US Patent Number : 6534524*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 202324

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-10-29

blank